Birgitta Versluijs

147 Outcome predictors in Allo-LS in children 1. Radhakrishnan SV, Hildebrandt GC. A call to arms: a critical need for interven- tions to limit pulmonary toxicity in the stem cell transplantation patient popu- lation. Current hematologic malignancy reports. 2015;10(1):8-17. 2. Ahya VN. Noninfectious Acute Lung In- jury Syndromes Early After Hematopoie- tic Stem Cell Transplantation. Clinics in chest medicine. 2017;38(4):595-606. 3. Vande Vusse LK, Madtes DK. Early On- set Noninfectious Pulmonary Syndro- mes after Hematopoietic Cell Trans- plantation. Clinics in chest medicine. 2017;38(2):233-48. 4. Versluys B, Bierings M, Murk JL, Wolfs T, Lindemans C, Vd Ent K, et al. Infec- tion with a respiratory virus before he- matopoietic cell transplantation is asso- ciated with alloimmune-mediated lung syndromes. The Journal of allergy and clinical immunology. 2017. 5. Soubani AO, Pandya CM. The spectrum of noninfectious pulmonary complicati- ons following hematopoietic stem cell transplantation. Hematology/oncology and stem cell therapy. 2010;3(3):143-57. 6. Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, et al. TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consor- tium and Children’s Oncology Group Study (ASCT0521). Biol Blood Marrow Transplant. 2015;21(1):67-73. 7. Williams KM. How I treat bronchiolitis obliterans syndrome after hematopoie- tic stem cell transplantation. Blood. 2017;129(4):448-55. 8. Versluys AB, Rossen JW, van Ewijk B, Schuurman R, Bierings MB, Boelens JJ. Strong association between respiratory viral infection early after hematopoie- tic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndro- mes. Biol Blood Marrow Transplant. 2010;16(6):782-91. 9. Versluys AB, van der Ent K, Boelens JJ, Wolfs T, de Jong P, Bierings MB. High Diagnostic Yield of Dedicated Pulmona- ry Screening before Hematopoietic Cell Transplantation in Children. Biol Blood Marrow Transplant. 2015;21(9):1622-6. 10. Panoskaltsis-Mortari A, Griese M, Mad- tes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic So- ciety research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneu- monia syndrome. American journal of respiratory and critical care medicine. 2011;183(9):1262-79. 11. Jagasia MH, Greinix HT, Arora M, Wil- liams KM, Wolff D, Cowen EW, et al. Na- tional Institutes of Health Consensus Development Project on Criteria for Cli- nical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Sta- ging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389-401 e1. 12. Versluys AB, Bierings MB, Beek FJ, Boe- lens JJ, van der Ent CK, de Jong PA. High- resolution CT can differentiate between alloimmune and nonalloimmune lung disease early after hematopoietic cell transplantation. AJR American journal of roentgenology. 2014;203(3):656-61. 13. Parnham MJ, Erakovic Haber V, Giama- rellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacology & thera- peutics. 2014;143(2):225-45. 14. Watanabe S, Kasahara K, Waseda Y, Takato H, Nishikawa S, Yoneda T, et References 8